Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 3, 2023 2:31 PM 4 min read

Dow Jumps Over 300 Points; S&P 500 Rises 1.5%

by Lisa Levin Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday.

The Dow traded up 1.03% to 33,343.73 while the NASDAQ rose 1.92% to 11,682.86. The S&P 500 also rose, gaining, 1.51% to 4,041.51.

Check This Out: Top 5 Real Estate Stocks That Are Set To Fly In March

 

Leading and Lagging Sectors

  • Consumer discretionary shares rose 1.8% on Friday. Meanwhile, top gainers in the sector included Gaotu Techedu Inc. (NYSE:GOTU), up 17%, and Xponential Fitness, Inc. (NYSE:XPOF), up 14%.
  • In trading on Friday, consumer staples shares fell by 0.2%.

 

Top Headline

The ISM Services PMI fell to 55.1 in February from 55.2 in January, but came in above expectations of 54.5.

 

Equities Trading UP

  • Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares shot up 36% to $3.1994 after the company said data from a recent peer-reviewed clinical study demonstrated Bentrio's superior nasal residence time and rheological properties.
  • Shares of Ardelyx, Inc. (NASDAQ:ARDX) got a boost, shooting 35% to $3.8999 after the company reported better-than-expected Q4 sales results.
  • Seer, Inc. (NASDAQ:SEER) shares were also up, gaining 38% to $5.82 after the company reported better-than-expected Q4 EPS and sales results.

 

Equities Trading DOWN

Also Check This Out: Bitcoin Falls Below This Key Level; Conflux Becomes Top Loser

 

Commodities

In commodity news, oil traded up 1.4% to $79.23 while gold traded up 0.7% at $1,854.00.

Silver traded up 1.4% to $21.20 on Friday while copper rose 0.3% to $4.0885.

 

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 0.92%, London’s FTSE 100 gained 0.04% while Spain’s IBEX 35 Index rose 1.47%. The German DAX gained 1.64% French CAC 40 rose 0.88% and Italy’s FTSE MIB Index gained 1.56%.

The S&P Global Eurozone services PMI fell to 52.7 in February versus a preliminary reading of 53.0. German services PMI was revised lower to 50.9 in February compared to a preliminary estimate of 51.3, while French services PMI was revised higher to 53.1 in February from a flash reading of 52.8.

Italy’s GDP shrank by 0.1% quarter-over-quarter during the three months leading to December. The S&P Global Italy services PMI increased to 51.6 in February versus 51.2 a month ago. Spain services PMI climbed to 56.7 in February versus 52.7 in the prior month.

 

Asia Pacific Markets

Asian markets closed higher on Friday, with Japan’s Nikkei 225 gaining 1.56%, Hong Kong’s Hang Seng Index rising 0.68% and China’s Shanghai Composite Index gaining 0.54%. India’s S&P BSE Sensex climbed 1.8%.

The S&P Global Indian services PMI climbed to a 12-year high level of 59.4 in February, while Caixin China general services PMI rose to 55.0 in February from 52.9 in the prior month. The S&P Global Hong Kong PMI climbed to 53.9 in February versus 51.2 in January, while Japanese services PMI was revised higher to 54.0 during February.

 

Economics

  • The S&P Global Services PMI rose to 50.6 in February from a preliminary reading of 50.5 and compared to January's level of 46.8.
  • The S&P Global Composite PMI slipped to 50.1 in February versus from a preliminary reading of 50.2.
  • The ISM Services PMI fell to 55.1 in February from 55.2 in January, but came in above expectations of 54.5.

Now Read This: https://www.benzinga.com/news/23/03/31192039/insiders-selling-sunrun-applied-materials-and-2-other-stocks

 

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 105,384,010 cases with around 1,146,630 deaths. India confirmed a total of at least 44,687,160 cases and 530,770 deaths, while France reported over 39,630,950 COVID-19 cases with 165,000 deaths. In total, there were at least 680,386,210 cases of COVID-19 worldwide with more than 6,803,050 deaths.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarkets
ARDX Logo
ARDXArdelyx Inc
$7.390.95%
Overview
GOTU Logo
GOTUGaotu Techedu Inc
$2.164.35%
NPCE Logo
NPCENeuroPace Inc
$15.47-1.28%
PRAX Logo
PRAXPraxis Precision Medicines Inc
$319.57-%
SEER Logo
SEERSeer Inc
$1.821.68%
VERU Logo
VERUVeru Inc
$2.444.27%
XPOF Logo
XPOFXponential Fitness Inc
$8.55-%
  • Praxis Precision Medicines, Inc. (NASDAQ:PRAX) shares tumbled 65% to $1.01 after the company announced topline results from the Essential1 study evaluating the efficacy, safety, and tolerability of ulixacaltamide (PRAX-944) for essential tremor (ET).
  • Shares of Veru Inc. (NASDAQ:VERU) were down 39% to $2.30 after the FDA declined to grant the company's request for Emergency Use Authorization for sabizabulin.
  • NeuroPace, Inc. (NASDAQ:NPCE) was down, falling 19% to $3.44 after the company reported Q4 financial results.
ARDX Logo
ARDXArdelyx Inc
$7.390.95%
Overview
GOTU Logo
GOTUGaotu Techedu Inc
$2.164.35%
NPCE Logo
NPCENeuroPace Inc
$15.47-1.28%
PRAX Logo
PRAXPraxis Precision Medicines Inc
$319.57-%
SEER Logo
SEERSeer Inc
$1.821.68%
VERU Logo
VERUVeru Inc
$2.444.27%
XPOF Logo
XPOFXponential Fitness Inc
$8.55-%
Comments
Loading...